you are viewing a single comment's thread.
price action today is very strange. It traded up to $20 in the fter hours friday, on heavy volume and today ALKS completely diverges from AMLN pattern. Maybe it's related to ALKS upcoming earnings?
Earnings? You mean another quarterly loss report??Lots of promise here, but downside remains a slippery sloop.When does the booz drug get traction?FDA was good news, but that doesn't translate into cash in the bank for quite some time.
I believe that AMLN was OK'd to start selling Byduereon effective immediately. So, ALKS should be seeing their % od revenue starting in Feb.